GlassScriptPhysician profile
David K Bush
NPI 1356354187
$1,481.76
in general payments reported to CMS, 2019-2025
17 companies · $32.25 in 2025
The $32.25 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.21 · 2020: $20.43 · 2021: $350 · 2022: $289 · 2023: $298 · 2024: $419 · 2025: $32.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $725.02 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.52 | 2022-2024 | Jardiance |
| Abbott Laboratories | $122.62 | 2021-2024 | Assurity, Confirm Rx |
| Pfizer INC. | $86.23 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $63.31 | 2023-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.24 | 2021-2024 | Lifevest |
| Esperion Therapeutics, INC. | $46.40 | 2021 | |
| Janssen Pharmaceuticals, INC | $39.57 | 2021 | |
| Chiesi USA, INC. | $37.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $36.03 | 2023-2024 | Evkeeza |
| Atricure, INC. | $24.58 | 2024 | |
| Novo Nordisk INC | $23.22 | 2024 | Ozempic |
| Vifor Pharma, INC. | $20.43 | 2020 | |
| Boston Scientific Corporation | $20.24 | 2024 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $14.75 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $14.55 | 2023 | Zio Xt Patch |
| Philips North America LLC | $13.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.